https://www.regeneron.com/ Regeneron: Meant for More At Regeneron, we move science to medicine because our world is meant for more. 99 https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx https://player.vimeo.com/video/945873223 Regeneron ISEF: A Program of Society for Science The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020. 59 https://www.regeneron.com/getattachment/6af089e3-e96e-4ce6-b108-e3ddefa13cac/attachment.aspx https://player.vimeo.com/video/882648601 Regeneron: Spectacular Science We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases. 25 https://www.regeneron.com/getattachment/64efb71c-1400-4642-853f-be365fb4c96b/attachment.aspx https://player.vimeo.com/video/735435161 Regeneron: Life-Changing Medicines We're driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development. 230 https://www.regeneron.com/getattachment/44587c69-80e7-4629-ac21-de8c2f2bc697/video-thumb-home-life-changing-medicines.jpg https://player.vimeo.com/video/930750815 Regeneron: Doing Well by Doing Good We're dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us. 154 https://www.regeneron.com/getattachment/getattachment/1cc580f9-9ff0-4695-aeab-2a1affaafc33/vidThumb-responsibility-approach-hero.png https://player.vimeo.com/video/930751500 https://www.regeneron.com/about/our-company Regeneron: Meant for More At Regeneron, we move science to medicine because our world is meant for more. 99 https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx https://player.vimeo.com/video/945873223 https://www.regeneron.com/about/leadership/leonard-schleifer Reflecting on Achievements For nearly 35 years, our mission has been to use the power of science to bring new medicines to patients. To achieve this, we seek to constantly improve the drug discovery and development process by applying our homegrown technologies, our deep understanding of science and our relentless spirit. 230 https://www.regeneron.com/getattachment/96fd2af4-dc1f-4f37-9763-777cb1ad88e8/video-thumb-home-life-changing-medicines.jpg https://player.vimeo.com/video/930750815 https://www.regeneron.com/about/leadership/george-yancopoulos George's Story Our board co-Chair, president and chief scientific officer, George Yancopoulos, followed in his grandfather's footsteps to pursue science. Watch to find out how he works every day to invent and discover the next new medicine that makes a difference in patient lives. 118 https://www.regeneron.com/getattachment/af0f0578-2042-40fc-b1ab-5f00dae6f986/vid-thumb-leader-bio-george.png https://player.vimeo.com/video/321518994 https://www.regeneron.com/science/research-development OUR GREATEST DISCOVERIES HAVE YET TO BE MADE We use science to solve the human body's most complex mysteries. With our deep expertise in genetics, biology and technology, we pursue multiple therapeutic approaches - from biologics to genetic medicines to cell therapies - to revolutionize medicine. 60 https://www.regeneron.com/getattachment/9de9f828-7e58-4178-9639-506483d1219d/vidThumb-science.jpg https://player.vimeo.com/video/741128019 The RGC Effect Our scientific philosophy centers on applying our understanding of biology and human genetics to identifying potential new and effective disease targets. We also tap into genetics to validate existing programs and optimize our clinical trials. By understanding the genetic underpinnings of the disease - when it is genetically-driven - we strive for a more precise approach to discovering and developing a treatment. Regeneron Genetics Center® (RGC) enables a deeper understanding of the genetic drivers of human health and disease through large-scale human genomics research. 149 https://www.regeneron.com/getattachment/4de959ad-14f3-4ecd-8e63-e7ddc2dd844c/vidThumb-rnd-2.png https://player.vimeo.com/video/874189168 Antibody Medicines Our scientists are leading the way, developing new technologies to help discover better and novel antibodies, including monoclonal, bispecific and costimulatory antibodies. Discover the past, present and future of antibody medicine. 108 https://www.regeneron.com/getattachment/0c1c17e9-2e8d-445c-b725-93267c716706/vidThumb-rnd-3.png https://player.vimeo.com/video/375675032 Genetic Medicines at Regeneron We realize different diseases need different approaches - and by following the science, we expanded our "toolbox" of therapeutic approaches to include genetic medicines. Learn about how we're combining our viral vector and antibody delivery capabilities with gene editing and more. 277 https://www.regeneron.com/getattachment/507e770b-2035-4a9c-baf4-c076d0cf17e5/vidThumb-science-genetics.jpg https://player.vimeo.com/video/885399549 Embed innovative technology into drug discovery and development We build proprietary technologies that help identify and advance the best-suited therapeutic approach for each disease. With nearly four decades of technology platform experience, we strive to create efficiencies and repeatability in drug development through the innovative use of groundbreaking technologies 230 https://www.regeneron.com/getattachment/26cb5538-3af1-4215-991b-caa821d1e1f1/vidThumb-rnd-5.png https://player.vimeo.com/video/930750815 Manufacture investigational and approved medicines with excellence and a continual improvement mindset in order to help patients around the world Our manufacturing team is similarly grounded in science and technology, and is integrated into our discovery and development process from the start. We invent new and optimize established processes to consistently produce high-quality and stable drugs for clinical trials and approved usage. By applying a deep understanding of the biochemical and biophysical properties of the drug with our proprietary platform technologies, we then produce our medicines for people in need at large scale. 169 https://www.regeneron.com/getattachment/229fc74f-2a67-46e6-b235-f658c30efe98/vidThumb-rnd-6.png https://player.vimeo.com/video/389781960 https://www.regeneron.com/science/research-development/oncology-hematology Our mission to transform cancer care Despite decades of progress, cancer still remains one of the world's most serious health problems. With nearly half of our pipeline dedicated to oncology and spanning more than 30 types of cancer, our research efforts are a testament to our relentless commitment to transforming cancer care for those who need it most. The unique flexibility of our internally developed pipeline drives the potential for novel and differentiated combination therapies. 60 https://www.regeneron.com/getattachment/50618a9d-63a6-4dc1-8b90-0a07a4143884/image2.png https://player.vimeo.com/video/945872980 How Regeneron Makes a Big Impact When it comes to potential treatments for those affected by cancer, we're looking to make a big impact. 60 https://www.regeneron.com/getattachment/77d2e1dd-e891-45cd-a774-516cd3fe6428/vidThumb-big-impact.png https://player.vimeo.com/video/906065031 Behind the Science: The Next Revolution in Blood Cancer Research Our commitment to helping patients is at the forefront of all we do. Hear from Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology, on how we're utilizing our deep scientific knowledge and proprietary technologies to research innovative approaches to blood cancer. 39 https://www.regeneron.com/getattachment/f4e62858-d3fb-47d0-96e6-fcc4eaa28f15/vidThumb-blood-cancer.png https://player.vimeo.com/video/945871632 Behind the Science: Defining Moments The cancer research landscape has made great strides over the last several years. Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology, shares his perspective on pivotal moments in research advancements in the field of oncology from his career. 76 https://www.regeneron.com/getattachment/e1f6e408-3294-433f-8777-4b5ab36f2ce0/vidThumb-defining-moments.png https://player.vimeo.com/video/945867525 Behind the Science: Loving What You Do We push the boundaries of science to help patients. Hear from Karen Rodriguez Lorenc, MD, Vice President, Global Program Head, Hematology and Translational Sciences, on why many former physician-scientists like herself are now on the frontlines of research. 53 https://www.regeneron.com/getattachment/6c234bdb-218e-424c-806c-c74b028f8e23/vidThumb-loving-what-you-do.png https://player.vimeo.com/video/945871740 Behind the Science: Paving the Way for Oncology Research Cancer research has come a long way since Regeneron first opened its doors 35 years ago. It's exciting to be one of the companies at the forefront of cancer research. Hear Matthew Fury, Executive Medical Director, Oncology Clinical Development, on how we are researching ways to unlock the power of the immune system for potential new solutions for patients and families in need. 57 https://www.regeneron.com/getattachment/251f0b53-025c-4ac0-bc50-ef88be9cbbdd/vidThumb-oncology-research.png https://player.vimeo.com/video/945872783 Behind the Science: Power of Science For Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology, the immuno-oncology revolution is just getting started, despite advancements over the past several years. Watch to learn more about his thoughts on the impact science has on advancing cancer research. 77 https://www.regeneron.com/getattachment/8381f8b8-9378-4321-b6c4-7823f5800258/vidThumb-power-of-science.png https://player.vimeo.com/video/945871538 https://www.regeneron.com/science/technology Overview Our industry-leading capabilities for antibody target discovery and validation are enabled by a series of Regeneron-invented technologies that accelerate, improve and disrupt the traditional process. 181 https://www.regeneron.com/getattachment/edfca9f9-6043-47df-b821-d4a3b7a4ee47/vidThumb-science-tech-overview.png https://player.vimeo.com/video/722582738 Velocigene VelociGene® enables rapid, automated and high-scale manipulation of mouse DNA, with almost no limitations on the size and sophistication of modifications. This enables unprecedented speed and capacity for the validation of therapeutic targets and the creation of animal models of human disease. We have a long history and deep expertise in mouse genetics — in 2006, VelociGene was selected by the National Institutes of Health (NIH) as part of its Knockout Mouse Project, an unprecedented effort to determine the function of thousands of unknown genes. Under the NIH grant, we took on the challenge of targeting 3,500 of the most difficult genes. 168 https://www.regeneron.com/getattachment/7080ba10-4a26-4699-b228-8d5ab69c2603/vidThumb-science-tech-velocigene.png https://player.vimeo.com/video/722584941 VelocImmune® VelocImmune is our unique technology for producing optimized fully human monoclonal antibodies. It utilizes a proprietary mouse platform engineered with a genetically humanized immune system. VelocImmune creates a multitude of antibody drug candidates efficiently and directly from immunized mice, overcoming limitations of traditional platforms by rapidly creating fully human antibodies that tightly bind to therapeutic targets and avoid potential negative immune responses that may occur in patients receiving antibodies that contain nonhuman (typically mouse) components. 167 https://www.regeneron.com/getattachment/1957f1af-e00b-4525-825c-0cbd8ef4578c/vidThumb-sicence-tech-velocimmune.png https://player.vimeo.com/video/722586084 Velocimab Velocimab® is a group of technologies that allow us to move with unprecedented speed from identification of a therapeutic antibody into clinical studies. VelociMab enables the high-throughput screening of potential therapeutic antibodies and the rapid generation of cell lines for recombinant human antibodies. It allows researchers to go from mouse immunization to production cell line bioreactor harvest within eight months. 145 https://www.regeneron.com/getattachment/78c6a716-5fec-46a4-87d0-11c80781befe/vidThumb-science-tech-velocimab.png https://player.vimeo.com/video/722588633 VelociMouse VelociMouse is a breakthrough technology that enables the immediate generation of genetically altered mice directly from modified embryonic stem cells, thereby avoiding the need to breed multiple generations of mice. This technology has dramatically shortened the time needed to engineer genetically modified mice, while at the same time reducing costs and improving precision. 125 https://www.regeneron.com/getattachment/d858c918-62e2-4081-9570-9ba9c6248def/velociMouse.png https://player.vimeo.com/video/284996740 Biology + Technology: A Love Story Harmonizing biology and technology 60 https://www.regeneron.com/getattachment/d49367e0-ba01-44f3-a39c-07ae2427e935/love-story-video.jpg https://player.vimeo.com/video/751422999 https://www.regeneron.com/science/technology/antibodies Antibodies as medicines Antibody medicines are based on key principles of biology and mimic the natural defenses and pathways of the human body and immune system. 108 https://www.regeneron.com/getattachment/96455aa5-269c-4faa-b179-8590a661272e/vidThumb-science-antibodies-abAsMedicine.png https://player.vimeo.com/video/375675032 Antibodies in allergic diseases Learn how Regeneron is exploring the use of antibody medicines to treat allergic diseases. 119 https://www.regeneron.com/getattachment/06d2dbfd-9df3-4569-94ca-4c0640f2d8f1/vidThumb-science-antibodies-abAndAllergies.png https://player.vimeo.com/video/375675336 Antibodies in immuno-oncology Regeneron is researching new ways to adapt and harness the special properties of bispecific antibodies to fight cancer. 166 https://www.regeneron.com/getattachment/6467dc65-ec63-4e43-af6c-6771bce0fe34/vidThumb-science-antibodies-abInImmunoOncology.png https://player.vimeo.com/video/375675148 Target discovery and validation 33 https://www.regeneron.com/getattachment/cd0b0f6d-1aa0-4ab3-8268-cec535534789/vidThumb-science-antibodies-discovery.png https://player.vimeo.com/video/318249756 VelociGene VelociGene rapidly tests and validates drug targets in mice and, in 2006, was selected as the technology of choice by the National Institutes of Health in the 'Knockout Mouse Project,' an unprecedented effort to determine the function of thousands of unknown genes. 209 https://www.regeneron.com/getattachment/5c52e5d3-ed4d-44cf-adac-2793cba818c5/vidThumb-sci-anti-velocigene.png https://player.vimeo.com/video/284996232 VelociMouse VelociMouse dramatically shortens the timeframe needed to engineer genetically modified mouse models, while reducing cost and improving precision. 125 https://www.regeneron.com/getattachment/d750818f-f0ee-4ad0-9420-55bec905cebe/vidThumb-sci-anti-velocimouse.png https://player.vimeo.com/video/284996740 VelociMab VelociMab enables high-throughput screening of potential therapeutic antibodies and the rapid generation of cell lines for recombinant human antibodies, a necessary step to arrive at the production scale needed for clinical testing. 164 https://www.regeneron.com/getattachment/126b1513-8d89-454a-a180-02562c950819/vidThumb-sci-anti-velocimab.png https://player.vimeo.com/video/284998231 VelocImmune VelocImmune is the leading platform for the efficient production of fully human antibodies. The genetically modified VelocImmune mouse is extraordinarily productive at generating antibodies that can be rapidly reformatted into medicines. While VelocImmune mice have been genetically modified to produce human antibodies, their immune systems have been precisely maintained to operate as those in normal mice. This enables a process of natural selection to produce optimized antibody candidates that are well-suited to become medicines, thereby increasing overall efficiency in the drug-development process. 180 https://www.regeneron.com/getattachment/67b114b7-aaad-4591-9d5d-97d4616749d7/vidThumb-sci-anti-velocimmune.png https://player.vimeo.com/video/284997534 https://www.regeneron.com/science/technology/genetic-medicines Unlocking the Potential of Genetic Medicines. View more on the science behind genetic medicines. 277 https://www.regeneron.com/getattachment/db4a047c-fe0d-4d07-932a-b9faeb290735/vidThumb-science-genetics-hero.png https://player.vimeo.com/video/885399549 Genetic Technologies at Work. Learn how we are leveraging our deep expertise and state-of-the-art technology to develop potentially life-changing genetic medicines. 45 https://www.regeneron.com/getattachment/b6e092d9-c22d-4085-9025-544fd221984c/vidThumb-science-genetics-techAtWork.png https://player.vimeo.com/video/885400247 Gene Editing Watch how we're turning gene editing into reality 60 https://www.regeneron.com/getattachment/da7175c3-4fe3-446e-ab91-219178f2b6bd/vidThumb-science-genetics-geneEditing.png https://player.vimeo.com/video/760346262 Regeneron Spectacular Science: Silencing Sickness Discover how we are working to 'silence sickness' 79 https://www.regeneron.com/getattachment/d55ccc8d-433b-4b7a-8ab1-b9144f9b10bf/vidThumb-science-genetics-geneSilencing.png https://player.vimeo.com/video/867248996 https://www.regeneron.com/science/genetics-center The RGC Effect Our scientific philosophy centers on applying our understanding of biology and human genetics to identifying potential new and effective disease targets. We also tap into genetics to validate existing programs and optimize our clinical trials. By understanding the genetic underpinnings of the disease - when it is genetically-driven - we strive for a more precise approach to discovering and developing a treatment. Regeneron Genetics Center® (RGC) enables a deeper understanding of the genetic drivers of human health and disease through large-scale human genomics research. 149 https://www.regeneron.com/getattachment/00d38633-5e0c-4b38-82b9-55edc69b4cc1/vidThumb-rgc-research.png https://player.vimeo.com/video/874189168 Rare mutation in GPR75 gene associated with reduced risk for obesity Through the genetic sequencing of nearly 650,000 people, our scientists discovered a rare genetic mutation in the GPR75 gene that is associated with reduced risk for obesity. We are pursuing therapeutic development programs using antibody, RNAi and small molecule approaches. 142 https://www.regeneron.com/getattachment/e9cedd94-3cf1-4a38-a0c2-29ee14750572/vidThumb-science-rgc-mutationGPR75.png https://player.vimeo.com/video/873413593 Rare mutations in CIDEB and HSD17B13 genes found to combat nonalcoholic steatohepatitis (NASH) CIDEB: We identified rare mutations in the CIDEB gene and discovered that those with one mutated copy of CIDEB had a 53% lower risk for nonalcoholic steatohepatitis (NASH). We are conducting preclinical research to develop a new medicine using an siRNA (gene silencing) approach. 145 https://www.regeneron.com/getattachment/39e6e7cc-3e9e-4dda-9276-fb9f22957e3f/vidThumb-science-rgc-mutationCIDEB.png https://player.vimeo.com/video/873413220 Data technology When it comes to our data technology, our goal is to minimize friction between the data and the insights we're trying to glean. 180 https://www.regeneron.com/getattachment/bba69027-7e85-4559-a3f8-37df3c8a58d3/vidThumb-science-rgc-dataTech.png https://player.vimeo.com/video/329861101 Our approach to genetic sequencing Our sequencing efforts are growing at a rapid pace, thanks to collaboration amongst teams to streamline the sample preparation and sequencing process. 163 https://www.regeneron.com/getattachment/8f0cf5cf-19bb-44b2-a9ba-66df0942b87b/vidThumb-science-rgc-geneticSequencing.png https://player.vimeo.com/video/329861183 https://www.regeneron.com/science/genetics-center/discoveries-collaboration Lund University Collaboration Learn about the benefits of open collaboration 30 https://www.regeneron.com/getattachment/61b4d9cc-41fc-4448-8378-1dc9b8a26aef/vidThumb-science-collab-2016-Lund-Univ.png https://player.vimeo.com/video/870375339 UK Biobank Collaboration Hear how our collaboration with UK BioBank helps accelerate discoveries and find determinants of disease. 52 https://www.regeneron.com/getattachment/f0165cf0-c46b-48dc-95f2-51fb20eb6b31/vidThumb-science-collab-2017-UK-biobank.png https://player.vimeo.com/video/870374093 1M Exomes Sequenced by RGC 30 https://www.regeneron.com/getattachment/8484e203-d78a-4ced-bbfe-dc32efe6c89b/vidThumb-science-collab-2020-exomes.png https://player.vimeo.com/video/870371097 Video with insights from publication release surrounding genetic associations discovered with clonal hematopoiesis of indeterminate potential (CHIP). 12 https://www.regeneron.com/getattachment/f328d753-d4ee-4c5f-bc6b-05ff5dccfdeb/vidThumb-science-collab-2022-chip.png https://player.vimeo.com/video/870362065 Video of Regeneron Genetic Center researchers sharing how they discovered the CIDEB mutations linked to reduced risk of metabolic associated steatohepatitis. 181 https://www.regeneron.com/getattachment/4695e5e9-267e-4106-bb30-e05567c4af74/vidThumb-science-collab-2022-steatohepatitis.png https://player.vimeo.com/video/750218896 Video explaining how ACE2 levels can influence an individual's risk for COVID-19. 39 https://www.regeneron.com/getattachment/ade6679a-cce6-44c1-ac1b-295866f32a29/vidThumb-science-collab-2022-covid19.png https://player.vimeo.com/video/870365346 Video explaining how ACE2 levels can influence an individual's risk for COVID-19. 7 https://www.regeneron.com/getattachment/269db5a6-5770-47cb-be4c-db94a42d48e6/vidThumb-science-collab-2022-mexico.png https://player.vimeo.com/video/870367783 Video explaining how ACE2 levels can influence an individual's risk for COVID-19. 7 https://www.regeneron.com/getattachment/14b154ed-6bbc-415c-b7a3-c8c6cc960eb0/vidThumb-science-collab-2023-ovarian-cancer.png https://player.vimeo.com/video/870359255 Video announcing Regeneron Genetic Center's collaboration with DiscoverMe South Africa. 30 https://www.regeneron.com/getattachment/200eb34d-2daa-4d09-a1f3-be57b04a9e63/vidThumb-science-collab-2023-south-africa.png https://player.vimeo.com/video/870360911 Validating Our Whole Exome Sequencing Approach 15 https://www.regeneron.com/getattachment/260bb658-dd45-4bce-aba2-ca69deb3bbf8/vidThumb-WGS-WES.png https://player.vimeo.com/video/1060959765 https://www.regeneron.com/medicines/making-our-medicines Highest-quality medicines for patients. Take a behind the scenes look at how we produce the highest-quality medicines for patients as efficiently as possible. 169 https://www.regeneron.com/getattachment/0a9aeeed-beb4-4c34-b13a-768c83464f40/our-medicines-video-img.jpg https://player.vimeo.com/video/389781960 https://www.regeneron.com/responsibility/our-approach Our approach to CORPORATE RESPONSIBILITY Our responsibility strategy uses Regeneron's unique knowledge and expertise to address the issues that matter most to our business and our stakeholders. Guided by our corporate philosophy of 'Doing Well by Doing Good,' our approach spans three strategic focus areas: improving the lives of people with serious diseases, fostering a culture of integrity and excellence and building sustainable communities. 154 https://www.regeneron.com/getattachment/a92850f1-c47a-418b-a9e7-feda8f878ab9/vidThumb-responsibility-approach-hero.png https://player.vimeo.com/video/930751500 https://www.regeneron.com/responsibility/stem-ecosystem-support The Next Generation's Heroes One of our most important endeavors at Regeneron is to advance the future of scientific innovation by nurturing young scientific talent. 121 https://www.regeneron.com/getattachment/eaa29bc7-e76a-477b-8b32-a3e7136868ff/vidThumb-next-gen-heroes.png https://player.vimeo.com/video/1013671993 The Together for CHANGE™ Initiative 57 https://www.regeneron.com/getattachment/0847d485-f1f2-420c-8357-b589eeb096f3/7.png https://player.vimeo.com/video/1006720451 https://www.regeneron.com/responsibility/stem-ecosystem-support/sts Our legacy with STS We are proud to have several STS alumni among our employee base, including Leonard Schleifer, our Board co-Chair, President and Chief Executive Officer and George Yancopoulos, our Board co-Chair, President and Chief Scientific Officer, who was an STS top winner in 1976. 204 https://www.regeneron.com/getattachment/1e401f11-1e9d-4d81-8607-073ffa65e371/vidThumb-responsibility-talent-search.png https://player.vimeo.com/video/284988273 https://www.regeneron.com/responsibility/stem-ecosystem-support/isef Regeneron: ISEF 59 https://www.regeneron.com/getattachment/02b3ac56-b37a-4851-8a4a-25b8656511dc/stem.jpg https://player.vimeo.com/video/882648601 https://www.regeneron.com/responsibility/community-impact Why We Volunteer 49 https://www.regeneron.com/getattachment/8f542e2b-22c8-414d-a57e-8a77a2f2906e/poster.jpg https://player.vimeo.com/video/1019857860 https://www.regeneron.com/responsibility/inclusion-culture Regeneron's Culture 173 https://www.regeneron.com/getattachment/0bb6ab2b-2fbb-43d8-9393-b4aa8bba42d3/21.png https://player.vimeo.com/video/814684869 https://www.regeneron.com/stories/science-talent-search https://www.regeneron.com/getattachment/5e45b69e-f445-43a3-aacc-2bfcfe2b0517/vidThumb-george-journey.jpeg Regeneron's chief scientist Watch George's journey to becoming Regeneron's chief scientist. https://player.vimeo.com/video/321518928 119 https://www.regeneron.com/stories/antibody-medicine https://www.regeneron.com/getattachment/8efda3fc-8d94-4e3e-96d7-8c16baa8b9be/vidThumb-pioneers.png How antibody medicines can help prevent diseases. Watch Drew Murphy explain how antibody medicines can help prevent diseases. https://player.vimeo.com/video/375675032 108 https://www.regeneron.com/stories/exome-sequencing-milestone https://www.regeneron.com/getattachment/dd994283-34d4-46e1-ba9d-091fa73c8d2a/vidThumb-million.png Momentous milestone Watch to learn more about this momentous milestone. https://player.vimeo.com/video/394287794 16 https://www.regeneron.com/stories/cideb-discovery https://www.regeneron.com/getattachment/13ff94cc-48e9-4b0a-b699-a3e810b847cb/vidThumb-better-together.png Approach behind the CIDEB Discovery Hear about the Team Science approach behind the CIDEB discovery. https://player.vimeo.com/video/750218896 70 https://www.regeneron.com/stories/together-for-change https://www.regeneron.com/getattachment/6dce8da0-ea93-4246-8b3c-040be5069819/vidThumb-rgc.png Better Togther Hear about Regeneron's Together for CHANGE Initiative. https://player.vimeo.com/video/873755352 57 https://www.regeneron.com/stories/modernizing-clinical-trials https://www.regeneron.com/getattachment/0bfe9e6e-bd15-44d9-87ef-1ce366d7178d/vidThumb-biomarkers.png Biomarkers Go Digital Biomarkers Go Digital - video with Bari Kowal https://player.vimeo.com/video/835922381 39 https://www.regeneron.com/stories/world-cancer-day https://www.regeneron.com/getattachment/44867656-ea17-40ab-bc37-175e05c87ce9/big-impact-video.jpg A Journey Through the Inner Ear Video about a journey through the inner ear https://player.vimeo.com/video/939136077 19 https://www.regeneron.com/stories/auditory-gene-therapy https://www.regeneron.com/getattachment/9d703109-ee2e-4e16-824f-3cfc17d6d795/vidThumb-inner-ear.png Big Impact Learn more about our vision to make a ‘Big Impact' for those affected by cancer https://player.vimeo.com/video/906065031 60 https://www.regeneron.com/stories/fueling-stem-innovation https://www.regeneron.com/getattachment/e7086e0c-c026-41b9-8d35-1a3e462650e0/vidthumb-vision.png Regeneron - STEM Education Video featuring various STEM programming produced or sponsored by Regeneron. https://player.vimeo.com/video/1013671993 121 https://www.regeneron.com/stories/a-world-without-cancer https://www.regeneron.com/getattachment/6a57903c-2628-4e8a-8102-84b184fc1ce2/thumb.jpg Regeneron: Meant for More At Regeneron, we move science to medicine because our world is meant for more. https://player.vimeo.com/video/1046454545 60 https://www.regeneron.com/stories/whats-your-legacy-clinical-trials https://www.regeneron.com/getattachment/3e8ac1ad-ffc0-44ee-83eb-9b1fe96bfc47/vidThumb-legacy.png What’s Your Legacy? Behind clinical trials are people — the doctors, nurses and researchers who dedicate their expertise to discovery, the patients who courageously participate, the families and friends who support them — all of whom are building a legacy of their own. Regeneron is grateful to all clinical trial participants who are a part of the legacy of medical advancement that can potentially impact the lives of the patients for decades to come. https://player.vimeo.com/video/1058363775 85 https://www.regeneron.com/stories/journey-to-hearing https://www.regeneron.com/getattachment/d121688f-e514-488b-946a-bbe886b1f06e/vidThumb-campbell-family.jpg A Journey to Hearing: The Power of Family A family's story of navigating hearing loss together https://player.vimeo.com/video/1059754341 450 https://www.regeneron.com/getattachment/dc623b9f-cb91-48a7-a447-d7cb52e37cd6/vidThumb-ANSD.jpg ANSD and Hearing Loss Watch this video to learn more about ANSD and the screening tests to consider with children displaying signs of hearing loss.​ https://player.vimeo.com/video/1059760876 230 https://www.regeneron.com/stories/science-with-purpose-responsibility-report https://www.regeneron.com/getattachment/4dfd9d8b-1c84-43ba-b786-aab88bfb1cce/vidThumb-MeantForMore-SciWithPurpose.jpg 2024 Responsibility Report captures the work, values and progress driving Regeneron forward. Our 2024 Responsibility Report highlights the progress we’ve made across three key focus areas: Improving the lives of people with serious diseases, Fostering a culture of integrity and excellence, Building sustainable communities​ https://player.vimeo.com/video/1070346169 80